Jacobs Levy Equity Management »

Halozyme Therapeutics shares owned by Jacobs Levy Equity Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Jacobs Levy Equity Management from 13F filings

Historical chart of Jacobs Levy Equity Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Jacobs Levy Equity Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Jacobs Levy Equity Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $66M 898k 73.34
2025-06-30 $52M 1.0M 52.02
2025-03-31 $12M 182k 63.81
2020-03-31 $3.6M 199k 17.99
2019-12-31 $3.1M 178k 17.73
2019-09-30 $7.6M 489k 15.51
2019-06-30 $9.1M 530k 17.18
2019-03-31 $7.4M 461k 16.10
2018-12-31 $4.8M 328k 14.63
2018-09-30 $6.4M 351k 18.17
2018-06-30 $5.3M 313k 16.87
2018-03-31 $5.0M 255k 19.59
2017-12-31 $1.5M 72k 20.26
2017-09-30 $631k 36k 17.38
2016-12-31 $479k 49k 9.88
2016-06-30 $165k 19k 8.64
2016-03-31 $176k 19k 9.46
2015-09-30 $171k 13k 13.46
2015-06-30 $327k 15k 22.55